EUVIMEDEUVIMED entdecken
Crossref

Multi-Omics Analysis Identifies Paxillin as a Biomarker of Doxorubicin Resistance via Cytoskeletal Remodeling and Immune Exhaustion

Yaoning Liu, Zhongjie Yao, Yilan Li iD, Hong Qing, Wei Xu iD

Journal of Proteome Research · 03.07.2026 · 25 (7) · 3716-3729

DOI: 10.1021/acs.jproteome.6c00278 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteome Research, online erschienen am 18.06.2026. Verfasst von Yaoning Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science, Beijing Institute of Technology, Beijing 100081, China. Hauptthemen laut MEDLINE: Doxorubicin, Paxillin, Drug Resistance, Neoplasm, Cytoskeleton. Die Arbeit nennt 84 Literaturangaben. Gefördert von: National Natural Science Foundation of China (NSFC), Beijing Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinPaxillinDrug Resistance, NeoplasmCytoskeletonBreast NeoplasmsBiomarkers, TumorHumansFemaleProteomicsTumor MicroenvironmentMultiomicsCell Line, TumorExtracellular MatrixFocal AdhesionsCell AdhesionGene Expression Regulation, NeoplasticAntibiotics, Antineoplastic

Stichwörter der Autor:innen

breast cancerchemotherapy resistancepaxillinproteomic landscapetumor microenvironment

Substanzen

DoxorubicinPaxillinBiomarkers, TumorPXN protein, humanAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • School of Life Science, Beijing Institute of Technology, Beijing 100081, China.
  • School of Medical Technology, Beijing Institute of Technology, Beijing 100081, China.
  • Analysis & Testing Center, Beijing Institute of Technology, Beijing 102488, China.

ORCID-Profile: Yilan Li, Wei Xu

Förderung

  • National Natural Science Foundation of China (NSFC)
  • Beijing Natural Science Foundation

Zitieren

APA

Liu, Y., Yao, Z., Li, Y., Qing, H., & Xu, W. (2026). Multi-Omics Analysis Identifies Paxillin as a Biomarker of Doxorubicin Resistance via Cytoskeletal Remodeling and Immune Exhaustion. Journal of Proteome Research, 25(7), 3716-3729. https://doi.org/10.1021/acs.jproteome.6c00278

Vancouver

Liu Y, Yao Z, Li Y, Qing H, Xu W. Multi-Omics Analysis Identifies Paxillin as a Biomarker of Doxorubicin Resistance via Cytoskeletal Remodeling and Immune Exhaustion. Journal of Proteome Research. 2026;25(7):3716-3729. doi:10.1021/acs.jproteome.6c00278

BibTeX
@article{Liu2026,
  author = {Liu, Yaoning and Yao, Zhongjie and Li, Yilan and Qing, Hong and Xu, Wei},
  title = {Multi-Omics Analysis Identifies Paxillin as a Biomarker of Doxorubicin Resistance via Cytoskeletal Remodeling and Immune Exhaustion},
  journal = {Journal of Proteome Research},
  year = {2026},
  volume = {25},
  number = {7},
  pages = {3716--3729},
  doi = {10.1021/acs.jproteome.6c00278}
}
Kostenlos starten →